CHEK1 and colon carcinoma: It has been reported that in human osteosarcoma and colon carcinoma, pharmacological or siRNA-mediated CHK1 inhibition leads to an increase in both the global replication rate and replication initiation and to a massive accumulation of DNA strand breaks [18].